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Farnesoic acid is a signaling molecule that inhibits the transition from budding yeast to ﬁlament
formation in Candida albicans, but the molecular mechanism regulated by this substance is
unknown. In this study, we analyzed the function of CaPHO81, which is induced by farnesoic acid.
The pho81D mutant cells existed exclusively as ﬁlaments under favorable yeast growth conditions.
Furthermore, the inhibition of hyphal growth and repression of CPH1, EFG1, HWP1, and GAP1mRNA
expression in response to farnesoic acid were defective in pho81Dmutant cells. These data suggest a
role for CaPHO81 in the inhibition of hyphal development by farnesoic acid.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Candida albicans, an opportunistic human pathogen, undergoes
a reversible morphogenetic transition between a budding yeast
form and a ﬁlamentous hyphal or pseudohyphal form. This dimor-
phism is thought to contribute to the virulence of the organism
[1–3]. The morphogenesis of C. albicans is triggered by various
environmental signals in vitro: serum, high temperatures, a high
ratio of CO2 to O2, and a neutral pH, and nutrient-poor media in-
duce the cells to sprout true hyphae. Conversely, low temperatures,
a high ratio of O2 to CO2, an acidic pH (4–6), and enriched media
promote yeast cell growth [4,5].
Many signaling pathways and regulators involved in hyphal
development have been identiﬁed as a result of strong molecular
conservation among C. albicans and Saccharomyces cerevisiae in
many cellular processes [6]. For example, a mitogen-activated pro-
tein kinase (MAPK) pathway involving CST20, HST7, CEK1, and
CPH1, and a cAMP-dependent protein kinase A (PKA) pathway
involving CAP1, TPK1, TPK2, and EFG1 promote ﬁlamentous growth
[7–12]. Furthermore, the small GTP-binding protein Ras1 is re-
quired for the regulation of both MAPK and cAMP-dependent
PKA pathways [13]. Three other C. albicans genes, TUP1, RFG1,
and NRG1, act to repress ﬁlamentous growth [14–17], but despite
these data, the regulatory mechanisms of dimorphism are poorlychemical Societies. Published by E
n), +82 2 873 3112 (K.-B. Oh).
g@snu.ac.kr (K.-B. Oh).understood, possibly because the upstream regulatory components
are unclear [18].
The dimorphism of C. albicans is controlled by at least two mor-
phogenic autoregulatory substances (ARSs), which accumulate in
the medium as the cells proliferate. Farnesoic acid and farnesol
are sesquiterpenes produced by C. albicans that act as ARSs to inhi-
bit hyphal development [18,19]. An in vitro inhibitory activity as-
say revealed that farnesoic acid exerted a weaker inhibitory
effect (IC50 = 4.56 lg/ml) than farnesol (IC50 = 2.82 lg/ml) [20].
However farnesoic acid had no detectable effect on yeast cell
growth at concentrations below 200 lg/ml, unlike farnesol
[18,20]. In C. albicans, farnesol reduces the expression of HST7
and CPH1, which are components of MAPK cascades [21], induces
the cell cyclin gene PCL2, and represses HGC1 and CLN3, which
are required for ﬁlamentous growth [22]. Recently, farnesol was
reported to inhibit a Ras1-mediated cAMP-dependent PKA path-
way [23]. Nevertheless, how these substances regulate C. albicans
hyphal development remains unknown because the regulatory fac-
tor controlled by these signaling molecules has not been identiﬁed.
Previously, we identiﬁed several genes that were upregulated
by farnesoic acid as a ﬁrst step toward elucidating the mechanism
of action for farnesoic acid in C. albicans morphogenesis [24]. Here,
we show that CaPHO81 induced by farnesoic acid is required for
inhibition of the yeast-to-hypha transition. CaPHO81 expression
was increased twofold by treatment with farnesoic acid within
40 min. The pho81D mutant cells existed exclusively as ﬁlaments
under favorable yeast growth conditions and were insensitive tolsevier B.V. All rights reserved.
Table 1
Strains and plasmids used in this study.
Strains or
plasmids
Genotype Ref.
Strains
SC5314 Prototrophic clinical isolate [40]
CAI4 Dura3::imm434/Dura3::imm434 [41]
CAG CAI4 Dpho81::hisG(I-SceI)-URA3-hisG(I-
SceI)/PHO81
This work
CAG4 CAI4 Dpho81::hisG(I-SceI)/PHO81 This work
CAG47 CAI4 Dpho81::hisG(I-SceI)-URA3-hisG(I-
SceI)/Dpho81::hisG(I-SceI)
This work
CAG4711 CAI4 Dpho81::hisG(I-SceI)/Dpho81::hisG(I-
SceI)
This work
Plasmids
pMB7 (I-SceI) hisG-URA3-hisG (I-SceI) in pUC18 [41]
pMB7-1 1–383 bp of PHO81 open reading frame in
BglII site of pMB7
This work
pMB7-2 3516–3993 bp of PHO81 open reading
frame in SalI site of pMB7-1
This work
pMB7-3 1–383 bp of PHO81 open reading frame in
SalI site of pMB7
This work
pMB7-4 3014–3458 bp of PHO81 open reading
frame in BglII site of pMB7-3
This work
YPB-ADHpt Promoter and terminator regions of ADH1
gene in YPB1
[42]
pADH-CaPHO81 CaPHO81 in YPB-ADHpt This work
pADH-Ras1 RAS1 in YPB-ADHpt This work
pADH-Ras1G13V RAS1G13V in YPB-ADHpt This work
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thermore, the cells showed defective repression of CHP1, EFG1,
GAP1, and HWP1 expression in response to farnesoic acid. These re-
sults indicate that CaPHO81 is a novel regulatory factor that func-
tions to repress ﬁlamentous growth, suggesting that it is required
for the inhibition of hyphal development in response to farnesoic
acid.
2. Materials and methods
2.1. Candida albicans strains and culture conditions
The C. albicans strains used in this study are indicated in Table 1.
Cells were grown in yeast extract/peptone/dextrose (YPD) medium
(1% yeast extract, 2% peptone, and 2% glucose), while strains carry-
ing plasmids or introduced gene disruption cassettes were grown
in SD medium (0.67% yeast nitrogen base without amino acids,
0.192% yeast synthetic dropout medium supplement without ura-
cil, and 2% glucose).
2.2. Gene disruption
To disrupt the ﬁrst chromosomal CaPHO81 allele, pMB7-2 was
digested with SalI and SacI, and 5 lg of the linearized pho81D::-
hisG-URA3-hisG gene disruption cassette was introduced into strain
CAI4 using the lithium acetate method [25]. To disrupt the second
chromosomal CaPHO81 allele, C. albicans PHO81/pho81D::hisG cells
(CAG4) were again transformed with the linearized pho81D::hisG-
URA3-hisG gene disruption cassette (i.e., pMB7-4 digested with SalI
and SacI). Spontaneous uridine auxotrophs were selected on media
containing 1 mg/ml 5-ﬂuoroorotic acid (5-FOA). The genotypes of
the mutant strains were conﬁrmed by PCR and Southern hybridiza-
tion (Supplementary Fig. 1).
2.3. Acid phosphatase assays
Acid phosphatase assays were performed using an Acid Phos-
phatase Assay Kit (Sigma, St. Louis, MO, USA) according to themanufacturer’s instructions. Cells were grown in 6 ml of high-
phosphate glucose minimal medium (10 mM phosphate), washed
in low-phosphate (10 lM) minimal medium, and then resus-
pended in 1 ml of low-phosphate medium. An aliquot was then
transferred to 20 ml of fresh high- or low-phosphate medium,
grown to an optical density at 600 nm of 0.3–0.5, washed in citrate
buffer (90 mM, pH 4.8), and resuspended in 100 ll of citrate buffer.
A total of 10 ll from each cell suspension was used in the acid
phosphatase assay.
2.4. Morphological characterization of the pho81D mutant
The wild-type cells (CAI4), pho81Dmutant cells (CAG4711) con-
taining empty YPB-ADHpt vector which carries the ADH1 pro-
moter, terminator sequence, and C. albicans URA3 (Table 1) were
streaked onto SD plates without uridine and incubated at 28 C
for 3–4 days. A single colony was inoculated in liquid media and
cultured at 28 C to the early stationary phase. To induce hyphal
growth, cells (1  107 cells/ml) were incubated in liquid media or
25 mM Tris–HCl buffer (pH 7.0) for 6 h at 37 C. For the farnesoic
acid inhibition assay, cells (1  107 cells/ml) were inoculated in
glucose-salts (GS) medium (5 g of glucose/0.26 g of Na2H-
PO412H2O/0.66 g of KH2PO4/0.88 g of MgSO47H2O/0.33 g of
NH4Cl/16 lg of biotin per liter) [18] and incubated for 6 h without
shaking at 37 C, with or without 20 lg/ml farnesoic acid.
2.5. Northern hybridization
Aliquots (10 lg) of total RNA were denatured and subjected to
1.2% agarose electrophoresis in the presence of 1 M formaldehyde.
The size-fractionated RNAs were then transferred to a nylon mem-
brane and ﬁxed by UV irradiation. CPH1-, EFG1-, TUP1-, HWP1-, and
GAP1-speciﬁc probes were generated using a Random Primer DNA
Labeling Kit (Takara Shuzo, Kyoto, Japan) with [a-32P]dCTP (Amer-
sham, Piscataway, NJ, USA). Radioactivity was detected using a Bio-
Imaging Analyzer System (BAS 2500; FujiFilm, Tokyo, Japan).
2.6. Detection of GTP-Ras1 in vivo
GTP-Ras1 was detected using an Active Ras Pull-Down and
Detection Kit (Thermo Scientiﬁc, Waltham, MA, USA) according
to the manufacturer’s instructions. A total of 1 mg of total protein
was incubated for 1 h at 4 C with GST-Raf1-RBD in the presence of
GST-agarose beads, washed, and eluted with 2 SDS sample buffer
(125 mM Tris–HCl, pH 6.8, 2% glycerol, 4% SDS, and 0.05% bromo-
phenol blue). The eluted proteins and 25 lg of total protein were
separated by SDS–PAGE, blotted onto PVDF membranes, and de-
tected with anti-Ras antibodies (1:500 dilution; Thermo Scientiﬁc).
Goat anti-mouse IgG-horseradish peroxidase (HRP) conjugate
(Thermo Scientiﬁc) was used as the secondary antibody in this pro-
cedure; protein bands were visualized with the ECL system using
SuperSignal West Pico Chemiluminescent Substrate (Thermo Sci-
entiﬁc). The ratio of GTP-Ras1/total Ras1 was determined by den-
sitometric analysis (Scion-Image Software, Frederick, MD, USA).
For the control reaction, total protein (1 mg) was incubated for
1 h at 4 C, either with 0.1 mM GTPcS or 1 mM GDP, and incubated
with GST-Raf1-RBD in the presence of GST-agarose beads (Fig. 6A).
3. Results
3.1. Identiﬁcation and characterization of CaPHO81
Previously, we identiﬁed several genes that are upregulated by
farnesoic acid [24]. Of these, CA11 expression was increased two-
fold by treatment with farnesoic acid for 40 min. CA11 shares
Fig. 2. Acid phosphatase assays of the wild-type (CAI4) and pho81D mutant
(CAG4711) cells. Cells grown under high (10 mM) or low (10 lM) phosphate
conditions were assayed for inducible acid phosphate activity using p-nitrophenol
phosphate as the substrate.
Fig. 1. Sequence of C. albicans Pho81. The SPX domain (A) and ankyrin repeats (B) in Pho81 from C. albicans and S. cerevisiae, as conceptually translated from their DNA
sequence, are compared. The alignment was performed using ClustalW; identities are highlighted. (C) The PHO81 gene products and relative arrangement of their N-terminal
conserved domains (black) and ankyrin repeat motifs (gray) are shown.
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Genome Database (http://candidagenome.org), which is thought
to be a homolog of S. cerevisiae PHO81, a cyclin-dependent protein
kinase (CDK) inhibitor. To conﬁrm the full-length cDNA sequence
of CA11, we performed 30 and 50 rapid ampliﬁcation of the cDNA
ends (RACE). Sequencing and conceptual translation revealed anopen reading frame (ORF) consisting of 1328 amino acids with
32% identity to Pho81 from S. cerevisiae over its entire length.
The SPX domain (residues 1–188) and six ankyrin repeats (residues
457–657) were conserved, and the primary sequence showed 52%
and 38% homology with ScPho81 (Fig. 1). We therefore renamed
the gene C. albicans PHO81 (GenBank Accession Number
DQ074694).
In S. cerevisiae, Pho81 inhibits the kinase activity of the Pho80-
Pho85 cyclin–CDK complex, resulting in the transcription of phos-
phate-responsive genes, including PHO5, an acid phosphatase gene,
under phosphate starvation conditions [26,27]. Therefore, to assess
the functional similarity between C. albicans PHO81 and S. cerevisi-
ae PHO81, we compared the acid phosphatase activity [28] in the
wild-type and pho81D mutant cells. Under low-phosphate condi-
tions, acid phosphatase activity in the pho81D mutant cells was
found to be 26%, compared to 100% in the wild-type cells (Fig. 2).
The results indicate that the CaPho81p is a phosphatases, and
therefore likely homolog of the yeast protein, ScPho81p, which is
also a CDK inhibitor. Whether Pho81p inhibits CDK remains to be
determined.
3.2. Deletion of CaPHO81 results in ﬁlamentous growth
To investigate the role of CaPHO81 in C. albicansmorphogenesis,
morphological differences between the wild-type and pho81Dmu-
tant cells were compared under the microscope. Both strains were
grown under conditions known to favor the yeast form (YPD). Un-
der these conditions, the wild-type cells exhibited the expected
Fig. 3. Morphological characterization of the pho81Dmutant. (A) Cells were incubated in YPD to the early stationary phase at 28 C or for 6 h at 37 C. (B) Cells were placed on
cornmeal agar plus Tween 80 (0.33%) plates under a coverslip and grown for 20 h at 25 C. Photographs were taken at a magniﬁcation of 40 with phase optics. Scale
bar = 50 lm.
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mainly in the ﬁlamentous form, creating more extended ﬁlaments
than wild-type cells at high temperatures (Fig. 3A). The pho81D
mutant cells expressing CaPHO81 under control of the ADH1 pro-
moter exhibited a wild-type phenotype. Similar results were ob-
tained when the cells were incubated in GS [18], Spider, SLAD, or
SHAD media (Supplementary Fig. 2). Heterozygous PHO81/pho81
cells showed an intermediate phenotype between the wild-type
and homozygous cells on nutrient-poor media such as cornmeal
agar by micro-aerobic growth under coverslips (Fig. 3B). The het-
erozygous cells were morphologically similar to the wild-type cells
on most media. These results suggest that CaPHO81 has a role in
suppressing ﬁlamentous growth.
3.3. The pho81D mutant cells do not respond to farnesoic acid
To determine whether CaPHO81 contributes to the inhibition of
hyphal development in C. albicans by farnesoic acid, we tested
farnesoic acid inhibition assay using previously described methods
[18]. The wild-type and pho81Dmutant cells were incubated in GS
medium with or without farnesoic acid (20 lg/ml) at 37 C for 6 h.
As expected, farnesoic acid inhibited hyphal development in wild-
type cells. The pho81D mutant cells grew exclusively as ﬁlaments
under farnesoic acid treated condition (Fig. 4A), although the ﬁla-
ments of the farnesoic acid-treated pho81D mutant cells were
shorter and thicker than those of the untreated cells. This observa-
tion indicates that the pho81D mutant cells exhibited ﬁlamentous
growth in the presence of farnesoic acid.
Hyphal development is regulated by MAPK and cAMP-depen-
dent PKA pathways, as well as the transcriptional repressor Tup1
[6]. To determine whether farnesoic acid contributes to one of
them in inhibition of the yeast-to-hypha transition, we compared
the transcript levels of CPH1, EFG1, and TUP1 in farnesoic acid-trea-ted cells with those in control cells. Northern blot analysis showed
that CPH1 and EFG1 mRNA expression was repressed in the farne-
soic acid-treated wild-type cells, but that TUP1 mRNA expression
was not (Fig. 4B). Furthermore, GAP1 and HWP1 mRNA, which rep-
resent Cph1- and Efg1-dependent genes speciﬁc for hyphal induc-
tion [29,30], respectively, decreased in farnesoic acid-treated C.
albicans. The repression of these genes was defective in farnesoic
acid-treated pho81Dmutant cells (Fig. 4C). These data suggest that
CaPHO81 acts downstream of the signaling pathways that regulate
the inhibition of hyphal growth by farnesoic acid, but upstream of
both MAPK and cAMP-dependent PKA pathways.
3.4. CaPHO81 contributes to regulation of Ras1 signaling
Because Ras1 is required for the regulation of both MAPK and
cAMP-dependent PKA pathways [13], we next assessed whether
CaPho81 contributes to regulation of the Ras1 signaling. CAI4-
Ras1 containing the wild-type RAS1 gene and CAI4-Ras1G13V carry-
ing a dominant-active RAS1 gene were incubated in 25 mM Tris–Cl
(pH 7.0) buffer at 37 C with no added inducer. The CAI4-Ras1G13V
strain formed hypha under these conditions, whereas the CAI4-
Ras1 strain did not (Fig. 5A). Thus, hyperactivation of the Ras1 sig-
naling pathway due to the presence of a dominant-active Ras1 var-
iant (Ras1G13V) resulted in hyphal growth under these conditions.
Following incubation with 20 lg/ml farnesoic acid under the same
conditions, hyphal formation was inhibited in the CAI4-Ras1G13V
strain, but not in the pho81D-Ras1G13V strain (Fig. 5B). These re-
sults were shown that CaPHO81 is required for inhibition of Ras1
signaling by farnesoic acid.
Ras proteins are members of the small GTPase superfamily,
which cycle between an inactive GDP-bound and an active GTP-
bound form [31]. The active form of Ras stimulates downstream
signaling pathways through direct interactions with effectors such
Fig. 4. Response of the pho81D mutant cells to farnesoic acid. (A) The wild-type (CAI4) and pho81D mutant (CAG4711) cells containing YPB-ADHpt were incubated in GS
medium with 1% dimethyl sulfoxide (FA) or 20 lg/ml farnesoic acid (+FA) for 6 h at 37 C. Photographs were taken at a magniﬁcation of 40 with phase optics. Scale
bar = 50 lm. (B) The wild-type (CAI4) and (C) pho81D mutant (CAG4711) cells containing YPB-ADHpt were incubated in GS medium with (+FA) or without (FA) 20 lg/ml
farnesoic acid for the indicated times at 37 C.
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bound Ras1 in vivo in the wild-type and pho81Dmutant cells using
an active Ras pull-down assay, which exploits the speciﬁc interac-
tion between GTP-Ras and the Ras-binding domain (RBD) of Raf-1
[33–35]. We ﬁrst found that RBD-Raf1 speciﬁcally interacted with
GTP-Ras1 (Fig. 6A). Our active Ras pull-down assay results using
total protein extracts from the wild-type and pho81D mutant cells
indicate that the GTP-Ras1 levels in the pho81D mutant cells were
twofold higher than those in the wild-type cells (Fig. 6B and C).
These observations imply that CaPHO81 contributes to regulation
of the Ras1 signaling in inhibition of hyphal development by farne-
soic acid.4. Discussion
Farnesoic acid is a morphogenetic autoregulatory substance
that accumulates in the medium as cells proliferate [18]. This mol-
ecule does not affect yeast cell growth, but it does inhibit hyphal
development. However, the molecular mechanism underlying
farnesoic acid’s role in C. albicans morphogenesis is unclear. In this
study, we found that CaPHO81 is required for the inhibition of hy-
phal development by farnesoic acid. CaPHO81 expression de-
creased in hyphal cells relative to yeast cells (Supplementary
Fig. 3); speciﬁcally, it increased twofold following treatment with
farnesoic acid within 40 min [24]. We also found that the inhibi-
Fig. 5. CaPHO81 was required for inhibition of the hyperactive Ras1 signaling by
farnesoic acid. (A) The wild-type (CAI4) cells containing pADH-Ras1 or pADH-
Ras1G13V were incubated in 25 mM Tris–HCl buffer (pH 7.0) for 6 h at 37 C. (B) The
wild-type (CAI4) and pho81D (CAG4711) cells containing pADH-Ras1G13V were
incubated in 25 mM Tris–HCl buffer (pH 7.0) for 6 h at 37 C with (+FA) or without
(FA) 20 lg/ml farnesoic acid.
Fig. 6. The C. albicans pho81D cells show increased GTP-bound Ras1 levels. (A) For the c
YPB-ADHpt was bound to GTPcS or GDP (Exposure time to ECL system: 1 min). (B) Total
cells were incubated with GST-Raf1-RBD in the presence of GST-agarose beads. The boun
Ras1) and 15 ll of eluted proteins were separated by SDS–PAGE. Ras1 was detected by im
The GTP-Ras1/total Ras1 ratio was determined by densitometric analysis.
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tant cells was defective (Fig. 4A). Previously, a study reported that
farnesoic acid inhibited hyphal growth, resulting in the conversion
of hyphal tips into yeast cells [18]. Under our conditions, no such
conversion was observed in farnesoic acid-treated pho81D mutant
cells (data not shown). Furthermore, the repression of CPH1, EFG1,
HWP1, and GAP1 in response to farnesoic acid was defective in the
pho81D mutant cells (Fig. 4C). These data suggest that CaPHO81 is
required for the inhibition of hyphal development by farnesoic
acid.
CaPho81 shows 32% identity with S. cerevisiae Pho81, which is a
CDK inhibitor that regulates the phosphate-responsive signal
transduction pathway (i.e., PHO pathway). The NH2-terminus of
CaPho81 contains an SPX domain involved in G-protein-associated
signal transduction [36], and ankyrin repeats with homology to the
p16INK4 class of mammalian CDK inhibitors implicated in protein–
protein interactions [37,38]. The SPX and ankyrin repeat domain in
the two proteins show a high degree of primary sequence conser-
vation (Fig. 1). Our data indicate that the deletion of CaPHO81 re-
sults in defective regulation of the PHO pathway (Fig. 2).
Moreover, the pho81D mutant cells formed ﬁlaments under favor-
able yeast growth conditions, although the ﬁlamentous growth of
the pho81D mutant was not the result of defects in the PHO path-
way because the medium used contained high levels of phosphate.
These data support the role of CaPHO81 in the inhibition of hyphal
development by farnesoic acid.
Hyphal development in C. albicans is regulated by the MAPK,
cAMP-dependent PKA, and Ras1-mediated signaling pathways
[6]. A study reported that the transcript levels of CPH1 and HST7
were reduced by treatment with farnesol, whereas the transcrip-
tion of HWP1, ALS1, and HYR1, which is strongly induced by Efg1,
did not change [21]. Other studies have shown that HWP1 expres-
sion is decreased by treatment with farnesol [39]. These reports
indicate that ARSs, including farnesoic acid and farnesol, affect
many signaling pathways and regulators of hyphal development.
Recently, farnesol was reported to inhibit the Ras1-mediated
cAMP-dependent PKA pathway [23]. The treatment of C. albicans
with farnesol represses the hyperﬁlamentation phenotype and res-ontrol reaction, 1 mg of total protein extracted from the wild-type cells containing
proteins (1 mg) extracted from the wild-type (CAI4) and pho81Dmutant (CAG4711)
d proteins were eluted with 2 SDS sample buffer. The 25 lg of total proteins (total
munoblotting with anti-Ras antibodies (Exposure time to ECL system: 20 min). (C)
S.-C. Chung et al. / FEBS Letters 584 (2010) 4639–4645 4645cues the heat shock sensitivity induced by dominant-active Ras1.
We identiﬁed that CaPHO81 acts upstream of both MAPK and
cAMP-dependent PKA pathways (Fig. 4) and required for inhibition
of the hyphal development induced by hyperactive Ras1 signaling
in response to farnesoic acid (Fig. 5). Furthermore, the pho81Dmu-
tant cells showed increased GTP-bound Ras1 levels relative to
wild-type cells (Fig. 6), in addition to increased heat shock sensitiv-
ity and invasive growth (data not shown). These observations sug-
gest that CaPho81 impacts Ras1 signaling in the inhibition of
hyphal development by farnesoic acid. Although how CaPho81 reg-
ulates Ras1 signaling in response to farnesoic acid is unclear, these
ﬁndings have important implications for our understanding of the
mechanism of hyphal development and virulence in pathogenic
fungi.
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